(Q21296643)

26 August 2022

Julia A Golier

1

Julia A

Golier

1 reference

26 August 2022

Kimberly Caramanica

series ordinal

2

author given names

Kimberly

author last names

Caramanica

1 reference

26 August 2022

Rebecca Demaria

series ordinal

3

author given names

Rebecca

author last names

Demaria

1 reference

Depression Research and Treatment

26 August 2022

language of work or name

English

0 references

publication date

2012

0 references

published in

1 reference

Creative Commons Attribution 3.0 Unported

volume

2012

0 references

page(s)

393251

0 references

copyright license

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Mifepristone: bioavailability, pharmacokinetics and use-effectiveness

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348629

An open label trial of C-1073 (mifepristone) for psychotic major depression

30 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F393251

Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F393251

Systemic and intrahippocampal administrations of the glucocorticoid receptor antagonist RU38486 impairs fear memory reconsolidation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F393251

Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F393251

21 January 2018

Identifiers

0 references

0 references